On a *non-GAAP basis, InMode reported net income of $24.5 million, or $0.38 per diluted share, in the third quarter of 2025, compared to $55.0 million, or $0.70 per diluted share, in the third quarter ...

Despite a highly profitable business model and a strong position in the medical aesthetics industry, INMD stock is down -33% over the last 12 months. Macroeconomic pressures, political risks in InMode ...

InMode Ltd. INMD shares are up during Friday’s premarket session after the company announced a new share repurchase program. InMode’s Board of Directors has authorized a new share repurchase program ...

InMode (NASDAQ:INMD) is gearing up to announce its quarterly earnings on Tuesday, 2026-02-10. Here's a quick overview of what investors should know before the release. Analysts are estimating that ...

This article was published on Feb. 24, 2026, at 10:15 a.m. on the ChosunBiz MoneyMove site. Global aesthetic medical device corporation InMode, listed on the U.S. Nasdaq, has decided to suspend the ...

InMode (INMD) designs, develops, manufactures, and markets minimally invasive aesthetic medical products. In addition, it designs, develops, manufactures, and markets non-invasive medical aesthetic ...

SAN DIEGO--(BUSINESS WIRE)--The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers of InMode Ltd. (NASDAQ: INMD) common stock between June 4, 2021 and October 12, 2023, inclusive ...

There were two different stories for InMode (NASDAQ: INMD) in 2022. In the first half of the year, the medical device stock plunged 68%. However, in the second half, InMode roared back, with its ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

On Wednesday, 11 March 2026, InMode Ltd (NASDAQ:INMD) presented its strategic vision at the Barclays 28th Annual Global Healthcare Conference. The company, navigating a challenging market environment, ...